Chemistry Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,516
Closed -$201K 202
2025
Q3
$201K Sell
2,516
-412
-14% -$35.1K 0.04% 198
2025
Q2
$266K Buy
2,928
+1
+0% +$91 0.06% 162
2025
Q1
$274K Buy
2,927
+1
+0% +$90 0.06% 150
2024
Q4
$266K Buy
2,926
+814
+39% +$77.7K 0.06% 149
2024
Q3
$219K Buy
2,112
+1
+0% +$102 0.05% 167
2024
Q2
$205K Buy
+2,111
New +$195K 0.05% 160

Other funds holding CL

Chemistry Wealth Management's CL Position: Q4 2025 in Review

Chemistry Wealth Management sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 2,516 shares — an estimated $201K sold.

Chemistry Wealth Management first reported a position in CL in Q2 2024 and held it in 6 quarters. The position peaked at $274K in Q1 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Chemistry Wealth Management reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Chemistry Wealth Management sold 2,516 Colgate-Palmolive shares in Q4 2025, an estimated $201K.
  • Chemistry Wealth Management first reported a position in Colgate-Palmolive in Q2 2024 and held it in 6 quarters.
  • Chemistry Wealth Management's Colgate-Palmolive position peaked at $274K in Q1 2025.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Chemistry Wealth Management's 13F filing for Q4 2025, filed 6 Jan 2026.